Zafgen Appoints Patrick Loustau As President - Quick Facts

By RTT News, 
A A A


(RTTNews.com) - Biopharmaceutical company Zafgen, Inc. ( ZFGN ) Tuesday said it has appointed Patrick Loustau as its President.

Most recently, he was the Senior Vice President for Global Commercialization (Cardiovascular & Metabolics) at Bristol-Myers Squibb Co. ( BMY ).

Loustau was previously with Novo Nordisk, where he held the most recent role of Senior Vice President for Global Marketing & Medical Affairs.

For comments and feedback: contact editorial@rttnews.com

http://www.rttnews.com



This article appears in: News Headlines

Referenced Stocks: BMY , NVO , ZFGN

RTT News


More from RTT News:

Related Videos

Stocks

Referenced

Most Active by Volume

39,889,386
  • $39.03 ▲ 0.98%
38,145,751
  • $17.165 ▲ 0.79%
28,918,262
  • $3.555 ▲ 0.99%
27,452,833
  • $102.21 ▲ 1.14%
23,428,201
  • $87.6087 ▼ 2.54%
22,702,627
  • $5.305 ▲ 3.82%
18,037,830
    $13.71 unch
16,960,675
  • $77.86 ▲ 1.38%
As of 9/23/2014, 12:13 PM